United States · 
Who invested in Neoantigenics?
Neoantigenics's investors include CIT GAP Funds and IrishAngels.
2015
?Round$3.0MVentureUnited States · Venture startup
Who invested in Neoantigenics
2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$3.0Mraised across 2 rounds since 2014, from 2 sources
- Latest round
- Venture, $3.0MFeb 2015
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round Apr 2014
- Biggest round
- $3.0M Venture · Feb 2015
- Between rounds
- 10 months from the last two
The rounds
- Feb 2015Venture$3.0M1 new
From a historical funding recordSEC filing: $3.0M sold, first sale Feb 2015
- Apr 2014
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Neoantigenics
How much has Neoantigenics raised?
Neoantigenics has raised $3.0M across 2 rounds since 2014. One round did not disclose an amount, so the total is a floor.
When did Neoantigenics last raise?
Neoantigenics's most recent round was a Venture of $3.0M in Feb 2015.
What was Neoantigenics's biggest round?
Its most recent round, $3.0M in Feb 2015, is also its largest on record.
Who backed Neoantigenics first?
Neoantigenics's first round on record, in Apr 2014, was backed by CIT GAP Funds.
What stage is Neoantigenics at?
Neoantigenics's latest named round is a Venture, in Feb 2015.
Where is Neoantigenics based?
Neoantigenics is based in the United States.
Companies like Neoantigenics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.